SEC Form 4 · accession 0001209191-19-004233
Outlook Therapeutics, Inc. · OTLK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Pankaj Mohan
Director · 10% Owner
Period of report
Jan 15, 2019
Accepted (ET)
Jan 17, 2019 · 4:45 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001649989
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 15, 2019 | P | 8,000 | $0.68 | A | 7,064,553 | D | |
| Common Stock | holding | — | — | — | 492,753 | I | By spouse | |
| Common Stock | holding | — | — | — | 39,405 | I | By minor child | |
| Common Stock | holding | — | — | — | 86,956 | I | By Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6649 - $0.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.